Text Size

a A

Menu

Mergers and Acquisitions

Sills Cummis & Gross mergers and acquisitions lawyers consistently lead transactions for a variety of companies, financial institutions and private equity firms across a wide range of industries.  Our M&A attorneys have broad experience in public and private M&A alike and focus on complex, multifaceted transactions.  Our clients receive personal attention of sophisticated M&A partners and ready access to tax, real estate, intellectual property, environmental law, litigation risk management and other disciplines required to deliver efficient and high quality legal service.  Moreover, our Firm’s association with ALFA International gives Sills Cummis & Gross exceptional cross-border capabilities, as well as local law capacity in key markets.

Expand All

Representative Matters

  • Representation of a multi-national automotive conglomerate in the acquisition of the stock of a competitor’s automotive manufacturing facility in South America, including the facilities, manufacturing unit, production lines and license to produce gasoline and flex fuel engines.  The target was a Brazilian company and a subsidiary of one of the Big 3 US auto companies, its ultimate parent company was a major US Private Equity Firm and the purchaser (our client) was an European company.  The value of the deal was approximately $127 Million.
  • Representation of a seller in a $77 million sale of a private New Jersey based business to a subsidiary of a Hong Kong Stock Exchange listed company.  We also represented certain principals of the seller and their affiliates in connection with numerous material agreements.
  • Representation of a private New York-based social network company in a reverse acquisition of a publically traded company where the equity holders of the social network company now have a controlling interest in the public company.  The transaction also involved an additional capital raise through a PIPE.
  • Representation of a Connecticut-based biotechnology company in connection with its execution of a Collaboration and License Agreement with a wholly-owned subsidiary of a NYSE listed biopharmaceutical company based in the United Kingdom that contemplated research, development and commercialization of biologics for the treatment of Alzheimer’s disease.
  • Representation of the selling stockholders of a New Jersey based company to a private equity-backed purchaser.  The target company is a provider of services to health care providers in the Mid-Atlantic region.
  • Representation of a Canadian-based manufacturer and importer of women’s apparel in a transaction involving the repurchase by the founders of a majority interest in the company from its private equity investors.  The transaction also involved the renegotiation and revision of the company’s financing facility with its bank lending group and its factor.
  • Representation of the selling stockholders of a New Jersey-based provider of investment management technology solutions for trust groups of financial institutions to a NASDAQ listed broker-dealer.

Press Releases

In the News

See all In the News

Publications

Practice Members

Practices